Reacción #40281

ord-ee129ff49d444468b0d5f9e3b6d54c78

Ecuación de reacción

CC1(C)OC[C@H](c2cnc(N)cn2)O1
5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine
CS(=O)(=O)c1ccc([C@@H](CC2CCCC2)C(=O)O)cc1Cl
2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-propionic acid
Cl
hydrochloric acid
c1ccncc1
pyridine
O=C(Cl)C(=O)Cl
oxalyl chloride
CC1(C)OC[C@H](c2cnc(NC(=O)[C@H](CC3CCCC3)c3ccc(S(C)(=O)=O)c(Cl)c3)cn2)O1
2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-propionamide
Rendimiento 92.4%

Condiciones de reacción

Temperatura
25°CELSIUS
Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    ConcentraciónThe reaction mixture was then concentrated in vacuo
  2. 2
    workup.DISSOLUTIONThe residue was dissolved in benzene (25 mL)
  3. 3
    Otrothe evaporation
  4. 4
    workup.DISSOLUTIONThe resulting acid chloride was dissolved in methylene chloride (40 mL)
  5. 5
    Temperaturacooled to at 0° C.
  6. 6
    workup.ADDITIONtreated with a solution
  7. 7
    workup.STIRRINGThe mixture was stirred for 16 h
  8. 8
    OtroThe layers were separated
  9. 9
    Extracciónthe aqueous layer was extracted with methylene chloride (75 mL)
  10. 10
    LavadoThe organic layers were washed with a saturated aqueous sodium bicarbonate solution (100 mL)
  11. 11
    SecadoThe combined organic layers were dried over sodium sulfate
  12. 12
    Filtraciónfiltered
  13. 13
    Concentraciónconcentrated in vacuo

Procedimiento

A solution of 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-propionic acid (prepared as in Example 1, 6.29 g, 19.01 mmol) and N,N-dimethylformamide (2 drops) in methylene chloride (70 mL) was stirred at 2° C. and then treated with oxalyl chloride (4.15 mL, 45.7 mmol). The mixture was stirred at 2° C. for 5 min and at 25° C. for 15 min. The reaction mixture was then concentrated in vacuo. The residue was dissolved in benzene (25 mL), and the evaporation was repeated. The resulting acid chloride was dissolved in methylene chloride (40 mL), cooled to at 0° C., and then treated with a solution composed of 5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-ylamine (3.65 g, 18.95 mmol), pyridine (4.6 mL, 56.9 mmol) and methylene chloride (40 mL). The mixture was stirred for 16 h without replenishing the cooling bath. The reaction mixture was then treated with a 1N aqueous hydrochloric acid solution (100 mL). The layers were separated, and the aqueous layer was extracted with methylene chloride (75 mL). The organic layers were washed with a saturated aqueous sodium bicarbonate solution (100 mL) and a saturated aqueous sodium chloride solution. The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo. Biotage chromatography (FLASH 40 L, Silica, 1/1 ethyl acetate/hexanes) afforded 2(R)-(3-chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-[5-((S)-2,2-dimethyl-[1,3]dioxolan-4-yl)-pyrazin-2-yl]-propionamide (8.9 g, 92%) as a white foam: (ES)+-HRMS m/e calcd for C24H30CiN3O5S (M+H)+ 508.1668, found 508.1671.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US07727750B2uspto-grants-2010_06